Friday 6 November 2026 Export GMED’s income statement to Excel — free account

Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue: −0.69%
EPS: +19.3%
Free cash flow: +10.1%

Quarter to September 2026, against a year earlier

70.93 10.51 −12.91%

Follow GMED

Alert me

Market cap: $10.9B
P/E: 19.5×
Fwd P/E: 18.8×
Dividend yield: —
F-score: 9/9
Altman Z: 11.30
Beneish M: −2.31
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Globus Medical, Inc. 8-K filed Jun 4, 2026

Period ended Jun 3, 2026 · Filed Jun 4, 2026 · accepted 4:11 PM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits

Red flags

Officer departure Jun 4, 2026
Globus Medical, Inc. reported the departure of an officer or director

8-K filed Jun 4, 2026 · The filing · sec.gov

Globus Medical, Inc. 8-K filed Jun 4, 2026

Red flags

Stockrow Weekly